OneSkin Raises $20M in Series A Funding

Scientist-founded skincare brand OneSkin has completed its Series A investment round, bringing total funding to $20 million. Led by Selva Ventures, the round saw contributions from PLUS Capital, Unilever Ventures, and Able Partners, alongside returning investors SOSV and MetaPlanet. Brazilian-American model and designer Camila Alves McConaughey also joined as an investor through PLUS Capital’s network of artists and athletes.

“As a Brazilian woman, I am thrilled to invest in a brand founded by four Brazilian female scientists – my heritage is something I’m incredibly proud of, and I am honored to support those who are executing this work,” expressed McConaughey. “The OneSkin team has built a line of products that hold a unique space in the massive skin care market. I fell in love with the products the moment I saw the results on myself, and I knew I had to be a part of it! I’m so looking forward to seeing their future innovations and continued success with the help of this funding.”

Founded in 2016 by four Brazilian PhD scientists, OneSkin is pioneering skin longevity treatments, standing out for its development of OS-01, a patented peptide that scientifically targets and reduces senescent cell accumulation—a key factor in ageing. This groundbreaking technology has been integral to OneSkin’s OS-01 Topical Supplements, crafted to support skin health and longevity by enhancing cellular function.

“This investment will allow us to deepen our commitment to be the best in class in delivering efficacious peptides to modulate aging at the cellular level, ensuring that our science-backed solutions deliver measurable results in promoting healthier skin,” said Dr. Alessandra Zonari, Co-Founder and CSO of OneSkin. “We are dedicated to advancing the future of skin health with the most advanced longevity research and innovation.”

“After working with the OneSkin team over the past two years, we are thrilled to deepen our partnership by leading their Series A round. This is our firm’s largest investment, reflecting our high conviction in the company and the team, led by Carolina and Alessandra,” says Madeline Kaplan, partner at Selva Ventures. “We are seeing the beauty and wellness spaces converge as more consumers want efficacious products that make them look and feel their best. OneSkin is well-positioned at the intersection of beauty and wellness, delivering exceptional results that improve both skin appearance and skin health.”

The new funding will fuel OneSkin’s research and development of innovative longevity solutions, support growth strategies, and expand distribution channels, making the brand’s advanced skincare more accessible to consumers worldwide.